Chlormethine

Mustargen

10 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1951

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Chlormethine

Mustargen

10 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1951

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LEDAGA Topical Gel 160 μg /gSingapore · 160 μg /g · gel · Pe Pharma Pte LTD

LEDAGA GelTaiwan · 凝膠劑 · 微功商行有限公司

ValchlorUnited States · 0.016% BASE · gel · Helsinn

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Chlormethine
Strength: 10 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1951
Registration: DIN 00016063
Marketing authorisation holder: Lundbeck Pharmaceuticals LLC
ATC code: L01AA05
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION